Cite
HARVARD Citation
Brizzi, F. et al. (n.d.). AB0234 AN INTEGRATED PROTEOMICS AND ANTIBODY ANALYSIS OF THE U-ACT-EARLY TRIAL TO IDENTIFY MARKERS OF TREATMENT RESPONSE AND DISEASE PROGRESSION IN EARLY RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases. p. 1574. [Online].